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Epileptic encephalopathyRare de novo mutations of sodium channels are thought to be an important cause of sporadic epilepsy. The well
established role of de novo mutations of sodium channel SCN1A in Dravet Syndrome supports this view, but the
etiology of many cases of epileptic encephalopathy remains unknown.We sought to identify the genetic cause in
a patient with early onset epileptic encephalopathy by whole exome sequencing of genomic DNA. The heterozy-
gous mutation c. 2003CNT in SCN8A, the gene encoding sodium channel Nav1.6, was detected in the patient but
was not present in either parent. The resulting missense substitution, p.Thr767Ile, alters an evolutionarily
conserved residue in the ﬁrst transmembrane segment of channel domain II. The electrophysiological effects of
this mutation were assessed in neuronal cells transfected with mutant or wildtype cDNA. The mutation causes
enhanced channel activation, with a 10 mV depolarizing shift in voltage dependence of activation as well as
increased ramp current. In addition, pyramidal hippocampal neurons expressing the mutant channel exhibit in-
creased spontaneous ﬁring with PDS-like complexes as well as increased frequency of evoked action potentials.
The identiﬁcation of this new gain-of-function mutation of Nav1.6 supports the inclusion of SCN8A as a causative
gene in infantile epilepsy, demonstrates a novel mechanism for hyperactivity of Nav1.6, and further expands the
role of de novo mutations in severe epilepsy.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).Introduction
Early-onset epileptic encephalopathy is a heterogenous disorder
characterized by seizures, developmental delay and progressive loss of
neurological function. Since most patients lack a family history, linkage
studies have not been feasible. Whole genome and exome sequencing
has provided important tools for identifying the genetic basis of this
devastating disorder. We identiﬁed and functionally validated a gain-
of-function mutation in SCN8A in a patient with epileptic encephalopa-
thy and SUDEP (Veeramah et al., 2012). This de novo mutation,
p.Asn1768Asp in sodium channel Nav1.6, results in impaired channel
inactivation and neuronal hyperactivity. We now describe the distinctesearch Center (Bldg 34), VA
06516, USA. Fax: +1 203 937
Human Genetics, 4909 Buhl,
Fax: +1 734 763 9691.
b-Hajj), meislerm@umich.edu
om).
. This is an open access article underfunctional consequence of a second de novomutation of SCN8A identiﬁed
in a patientwith amore severe epileptic encephalopathy. Since our initial
report, large-scale exome sequencing projects have identiﬁed eleven de
novomutations of SCN8A in singleton patientswith epilepsy and/or intel-
lectual disability (Carvill et al., 2013; Epi4KConsortiumet al., 2013; Rauch
et al., 2012; reviewed inO'Brien andMeisler, 2013). Another de novomu-
tation of SCN8Awas recently identiﬁed in a child with epileptic encepha-
lopathy and congenital anomalies (Vaher et al., 2013). Since genetic
evidence of linkage is not possible for de novomutations, functional stud-
ies and analysis of evolutionary conservation and population frequency
can contribute to assessing the pathogenicity of these mutations.
In addition to SCN8A, mutations associated with epilepsy have been
identiﬁed in SCN1A, SCN2A, and SCN3A, the other pore-forming α-
subunits of voltage-gated sodium channels that are expressed at high
levels in the CNS (Helbig and Lowenstein, 2013; Kullmann, 2010;
Lerche et al., 2013; Meisler et al., 2010). De novo mutations of SCN1A
account formore than 80%of Dravet Syndrome, and inheritedmutations
contribute to generalized epilepsy with febrile seizures plus (Hirose
et al., 2013; Meisler et al., 2010). Inherited and de novo mutations of
SCN2A have been linked to benign familial neonatal-infantile seizuresthe CC BY license (http://creativecommons.org/licenses/by/3.0/).
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mutations in SCN3A have been associated with cryptogenic partial
epilepsy (Estacion et al., 2010; Holland et al., 2008; Vanoye et al.,
2013).
Nav1.6 is widely expressed in CNS and PNS neurons (Caldwell et al.,
2000). Within neurons, Nav1.6 is concentrated at the axon initial
segment in both excitatory (Liu et al., 2013; Ogiwara et al., 2013; Oliva
et al., 2012) and inhibitory neurons (Lorincz and Nusser, 2008), where
it plays a critical role in regulating neuronal excitability (Hu et al.,
2009; Lorincz and Nusser, 2008; Vacher et al., 2008). Consistent with
this role in neuronal excitability, many types of neurons from Scn8a
null mice lacking Nav1.6 exhibit reduced excitability, including retinal
ganglion cells, hippocampal CA1 cells, and cerebellar Purkinje cells
(Raman et al., 1997; Royeck et al., 2008; Van Wart and Matthews,
2006; reviewed in O'Brien and Meisler, 2013). Nav1.6. is also the major
sodium channel at mature nodes of Ranvier (Boiko et al., 2001;
Caldwell et al., 2000; Kaplan et al., 2001; Lorincz and Nusser, 2010),
and reduced Nav1.6 results in slowed nerve conduction velocity
(Kearney et al., 2002). Nav1.6 produces a tetrodotoxin-sensitive (TTX-S)
fast-inactivating current (Sangameswaran et al., 1997; Smith et al.,
1998), a persistent current (Rush et al., 2005; Smith et al., 1998), and a
resurgent current (Cummins et al., 2005; Raman et al., 1997) and has
been associated with rapid burst ﬁring in cerebellar Purkinje neurons
(Khaliq et al., 2003; Raman et al., 1997). Scn8a null mice exhibit juvenile
lethality, demonstrating the essential role ofNav1.6 in vivo (Burgess et al.,
1995;Meisler et al., 2004; Sharkey et al., 2009).We report here the iden-
tiﬁcation and functional validation of a de novo Nav1.6 mutation in a pa-
tient with epileptic encephalopathy. Our data support the inclusion of
SCN8A as a causative gene in infantile epilepsy.Methods
Exome sequencing
Exome sequencing was carried out by the Medical Genetics
Laboratories/Whole Genome Laboratory at Baylor College of Medicine
(www.bcm.edu/geneticlabs). Variants were analyzed using in-house
developed software. A relevant variant of unknown signiﬁcance (VUS)
in the SCN8A gene was reported based on previously published reports
implicating this gene in epileptic encephalopathy (Veeramah et al.,
2012) and intellectual disability (Trudeau et al., 2006).Generation and expression of the mutant cDNA
The de novo SCN8A mutation c. 2300CNT (p.Thr767Ile) was intro-
duced into the tetrodotoxin (TTX)-resistant derivative of the Nav1.6
cDNA clone Nav1.6R (Herzog et al., 2003). In this cDNA, the amino acid
substitution Y371S confers TTX-resistance andmakes it possible to spe-
ciﬁcally study Nav1.6 in a biologically appropriate neuronal cell back-
ground (Dib-Hajj et al., 2009). Comparisons between TTX-resistant
wildtype andmutant cDNAs have facilitated the delineation of biophys-
ical changes produced by human mutations in Nav1.3, Nav1.6 and
Nav1.7 (Dib-Hajj et al., 2013; Estacion et al., 2010; Veeramah et al.,
2012).
After site-directed mutagenesis to introduce the p.Thr767Ile muta-
tion, the 6-kb open reading frame of the cDNA was completely
sequenced to conﬁrm the absence of additional mutations. Expression
of the mutant protein was conﬁrmed by transfection into HEK293
cells and analysis by Western blot with rabbit polyclonal anti-Nav1.6
(Alomone ASC-009, 1:100). To evaluate the functional consequences
of the p.Thr767Ile (T767I) mutation, the wildtype and mutant cDNAs
were tested in the neuronal cell line ND7/23 and in transfected hippo-
campal pyramidal neurons, as previously described (Sharkey et al.,
2009; Veeramah et al., 2012).Voltage-clamp recording
Forty-eight hours after transfection, ND7/23 cells with robust
green ﬂuorescence were selected for recording. In the presence of
300 nM TTX, endogenous sodium currents are blocked (Sharkey
et al., 2009; Wittmack et al., 2004) and currents derived from
Nav1.6R or T767I channels can be studied in isolation. Whole-cell
voltage-clamp recordings were performed at room temperature
(20–22 °C) using an HEKA EPC800 ampliﬁer (HEKA Electronik).
Fire-polished electrodes (0.6–1.3 MΩ) were fabricated from borosil-
icate glass micropipettes (World Precision Instruments). The pipette
potential was adjusted to zero before seal formation, and liquid junc-
tion potential was not corrected. Capacity transients were canceled
and voltage errors were minimized with 60–90% series resistance
compensation. Currents were acquired with Clampex 10.2 at 5 min after
establishingwhole-cell conﬁguration, sampled at a rate of 50 kHz, and ﬁl-
tered at 10 kHz. Activation and steady-state fast-inactivation of channels
were obtained as previously described (Sharkey et al., 2009).
Current-clamp recording in transfected hippocampal neurons
Animal protocols complied with NIH guidelines, and were approved
by the VA-Connecticut Healthcare System Animal Use Committee.
Sprague–Dawley rat pups of either sex between postnatal days 10
(P10) and 14 (P14) were deeply anesthetized by ketamine/xylazine
(100/10 mg/kg, i.p.) and killed by decapitation. Hippocampal neurons
were isolated, transfected and recorded as previously described
(Estacion et al., 2010; Veeramah et al., 2012). Recordings were per-
formed on transfected hippocampal pyramidal neurons based on the
morphology of small diameter (10–15 μm) triangular cell bodies that
also exhibited green ﬂuorescence. All recordings were performed
between 40 h and 50 h post-transfection. Whole-cell current-clamp
recordings were performed using the HEKA EPC800 ampliﬁer, digitized
using the Digidata 1440A interface and controlled using pCLAMP soft-
ware, as described previously (Estacion et al., 2010). HEKA EPC-800
patch-clamp ampliﬁer provides a low-frequency voltage-clamp (LFVC)
circuit. LFVC is a mode in which a target resting membrane potential
(−80 mV in this study) is speciﬁed; the clamp injects a continually
updated holding current during a current-clamp recording to maintain
the neuron resting potential near the target value.
Data analysis
Data were analyzed using Clampﬁt 10.2 (Molecular Devices) and
Origin 8.5 Pro (Microcal Software), and presented as means ± SE. The
Mann–Whitney nonparametric testwas used to analyze current density
data. Student's t test, except where ANOVA is speciﬁcally noted, was
used to assess the statistical signiﬁcance in characteristics of WT
Nav1.6R and the p.Thr767Ile mutant channels.
Results
Clinical description
The proband exhibits profound developmental delay, intellectual
disability and intractable epilepsy. Myoclonic jerks and stiffness were
observed in the neonatal period after an uncomplicated full term
birth. Hyperekplexia was conﬁrmed by EEG and clonazepam treatment
was initiated. Seizures began at twoweeks of age, when an EEG showed
multifocal epileptiform activity with a normal background and the MRI
was normal. An extensive genetic and metabolic workup was negative.
Daily tonic and myoclonic seizures continue, in addition to rare tonic
clonic seizures. At two years of age, an EEG revealed multifocal epilepti-
form activity with background slowing, and an MRI detected delayed
myelination. The longest seizure-free period has been 2 weeks. The
patient was ﬁrst treated with levetiracetam, with subsequent addition
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ment. After a recent hospital admission for increased seizures,
oxcarbazepine was added.
On physical examination at three years of age, the patient is mini-
mally responsive with no obvious dysmorphic features. There is pro-
found central hypotonia with some spasticity in the extremities.
Reﬂexes are 3+ with ankle clonus and the patient can lift extremities
against gravity spontaneously. The patient does not roll over, has
complete head lag, and does not ﬁxate or track. Feeding is by gastric
tube. There have been multiple hospital admissions for pneumonia.Mutation identiﬁcation
There was no family history of seizures or developmental delay and
there are two healthy older siblings. Genetic testing formutations in the
glycine receptor subunits GLRA1 and GLRB and the Rett Syndrome gene
MECP2were negative. Whole exome sequencing was carried out in the
Medical Genetics Laboratories at the Baylor College of Medicine and
revealed a heterozygous c.2300CNT variant in the SCN8A gene resulting
in the novel protein variant p.Thr767Ile in Nav1.6. The mutation was
conﬁrmed by Sanger Sequencing. Examination ofmaternal and paternal
DNA by Sanger Sequencing did not detect the variant, indicating that it
results from a de novo mutation, although the possibility of mosaicism
in either parent cannot be eliminated. The mutated threonine residue
is located within the ﬁrst transmembrane segment of domain II of the
channel (DII/S1; Fig. 1A). This residue is evolutionarily conserved in
vertebrate orthologs and invertebrate homologs of SCN8A (Fig. 1B).
Threonine 767 is invariant in all of the human sodium channels, which
diverged from a common ancestor more than 400 million years ago
(Zakon et al., 2011) (Fig. 1C). The extensive evolutionary conservation,
the location of the mutation in a transmembrane segment, and the re-
placement of the polar threonine residue with a bulkier hydrophobic
side chain, predict a deleterious effect of thismutation on channel activ-
ity. To test this prediction, the mutation was introduced into the Nav1.6
cDNA for functional characterization.Fig. 1. Location of the p.Thr767Ile mutation in Nav1.6 and evolutionary conservation of themuta
voltage-gated sodium channel alpha subunit. (B) This threonine residue is conserved in the ve
invertebrate channel fromDrosophila and Ciona. (C) Threonine (T) at position 767 is conserved i
and cardiac channels SCN4A and SCN5A, respectively.Voltage-clamp recordings of wildtype Nav1.6 and T767I currents
Whole-cell voltage-clamp recordings were performed on ND7/23
cells expressing either wild-type mNav1.6R (WT) or mNav1.6R-T767I
(T767I). The activation properties of the currents expressed by these
cells were tested by holding the cells at−120 mV and then applying
100 msec test pulses to potentials between −80 and +50 mV in
5 mV increments. Representative inward currents recorded by this
protocol are shown for WT and T767I channels (Fig. 2A). The current–
voltage plots derived from peak inward responses from individual
cells were averaged together and shown in Fig. 2B. Cells with a peak
amplitude N500 pA were included in measuring current density.
The peak current density for T767I channels (−64 ± 10 pA/pF, n =
14) was reduced approximately 2.5-fold compared to WT channels
(−167 ± 67 pA/pF, n = 11).Voltage-dependence of activation and fast-inactivation
The voltage-dependence of activation and fast-inactivation was ex-
amined by transforming the peak current versus voltage (I–V) curves
into conductance versus voltage (G–V) and ﬁt to a Boltzmann function
which directly gives the voltage midpoint (V1/2) as well as the slope
factor (k) of the voltage-dependent response. The Boltzmann ﬁts for
both activation and fast-inactivation were derived for each cell individ-
ually and then averaged. The averages of the normalized G–V curves for
activation are signiﬁcantly different with the V1/2Act of T767I shifted by
10.8 mV in a hyperpolarized direction (WT, n = 11: V1/2 =−17.9 ±
1.3 mV, k = 7.3 ± 0.2; T767I, n = 14: V1/2 = −28.7 ± 1.2 mV, k =
6.8 ± 0.6, p b 0.001) as shown in Fig. 2C. The average of the ﬁts
for fast-inactivation revealed similar properties for WT and T767I
channels (WT, n = 11: V1/2 =−65.9 ± 1.4 mV, k = 6.0 ± 0.4; T767I,
n = 14: V1/2 =−64.8 ± 1.6 mV, k = 7.0 ± 0.6) (Fig. 2D). The 10 mV
shift in voltage dependence of activation is sufﬁciently large to predict
signiﬁcantly increased excitability of neurons expressing the mutant
channel in vivo.ted residue. (A) Threonine 767 is located in transmembrane segment 1 of domain II of the
rtebrate SCN8A channel from reptile (a, anotole) and ﬁsh (f, Fugu) and in the homologous
n themembers of the human voltage-gated sodium channel gene family, includingmuscle
Fig. 2.Voltage-clamp analysis of Nav1.6 p.Thr767Ilemutant channels. (A) Representative traces recorded fromND7/23 cells expressingmNav1.6R (WT, black lines) and T767I (red lines) in
response to the activation stimulation protocol (100 msec duration pulses). (B) The peak currents are normalized for cell capacitance and then are averaged together to obtain the acti-
vation current–voltage (I–V) relation for cells expressingWT (black symbols) or T767I (red symbols) as described in theMethods section. (C) The G–V curves for bothWT (black symbols)
and T767I (red symbols) cell are normalized and then averaged to obtain the Boltzmann ﬁt for activation data,which shows hyperpolarizing shift of activation of T767I channels compared
toWT channels. (D) The responses to the fast-inactivation protocol are analyzed to obtain the voltage-dependence of fast-inactivation as described in theMethods section. The normalized
and averaged and the Boltzmann'sﬁt are shown for bothWT (black symbols) and T767I (red symbols). The voltage-dependence of fast-inactivation of T767I channels is not different from
that of WT channels. Error bars are standard error of themean (SEM). (E) The averaged currents evoked during a slow ramp stimulus beginning at−100mV and ending at 20mV over a
duration of 600ms are shown fromWT (black line, n= 6) and T767I (red line, n= 10) expressing cells. The traces have been normalized to themaximal peak current recorded from that
cell. T767I channels produce a larger normalized ramp current which peaks at a more hyperpolarized voltage compared to that of WT channels.
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We evaluated the response of WT and T767I channels to slow
depolarizations using a slow ramp protocol from a holding potential
of −100 mV to +20 mV over 600 ms for a ramp rate of 0.2 mV/ms.To compare the response in different cells, the responsewas normalized
to the peak inward current recorded during the activation I–V protocol.
The averaged response of WT and T767I channels is shown in Fig. 2E.
The peak ramp current of T767I averaged 3.1± 0.4% of the peak current
(n = 10), which is a 3-fold increase over the average ramp response of
Fig. 3. Neurons expressing Nav1.6-T767I exhibit an increase in spontaneous activity.
Continuous segments of current-clamp recording from hippocampal pyramidal neurons
illustrate patterns of spontaneous action potentialﬁring seen in a subset of cells expressing
T767I channels. (A1) Trace from a representative spontaneously active cell. Scale bar indi-
cates 20mV vertical, 5 s horizontal. (A2) A small region of the tracewas expanded to illus-
trate ﬁring behavior riding on top of transient depolarizations of themembrane potential,
paroxysmal depolarizing shift-like complexes, characteristic of epileptic discharges. Scale
bar indicates 20 mV vertical, 1 s horizontal. (B) Trace from a hippocampal pyramidal cell
expressing Nav1.6-WT with the same scaling as panel A1 for comparison. Scale bar indi-
cates 20 mV vertical, 5 s horizontal.
121M. Estacion et al. / Neurobiology of Disease 69 (2014) 117–123WTchannels (1.1± 0.2%, n=6; p= 0.003). This change is predicted to
increase channel activity in the range of subthreshold depolarizations
and enhance the probability of action potential ﬁring.
Current-clamp recording in pyramidal hippocampal neurons
To assess the effect of the p.Thr767ILe mutation on excitability, hip-
pocampal neurons from wildtype mice (P10–P14) were transfected
with either the WT or T767I construct and current-clamp recordings
were used to assess the pattern of ﬁring, including action potential
threshold and evoked ﬁring frequency in pyramidal neurons. Input
resistance of neurons transfected with wildtype channels (1.06 ±
0.53 GΩ)was not signiﬁcantly different from that of neurons expressing
the T767I mutant channels (1.25 ± 0.14 GΩ; p N 0.05) (Table 1). Since
the input resistance of the transfected hippocampal pyramidal cells is
high and in the same range as seal resistance, it is not informative to
measure actual resting membrane potential in the current-clamp
mode because of potential errors that could be as high as 50% of the
recorded value. Instead, we used on-line LFVC (see Methods). LFVC
holds the membrane potential of the transfected neurons near a target
potential of−80 mV so that differences in ﬁring activity are unlikely
to be due to differences of resting membrane potential, and can rather
be attributed to the altered properties of the mutant channels.
A notable difference between neurons transfected with T767I com-
pared to neurons transfected with WT channels was an increase in the
number of neurons that exhibited spontaneous ﬁring. T767I transfected
neurons showed spontaneous ﬁring of action potentials in 6 of 15 cells
while only 1 of 17 WT transfected neurons ﬁred spontaneously. The
majority of the T767I transfected neurons with spontaneous activity
also showed ﬂuctuations of resting membrane potential that elicited
bursts of action potentials (Fig. 3, panel A1). Paroxysmal depolarizing
shift-like complexes (PDS; Fig. 3 panel A2) were present in 4 of 6 spon-
taneously active neurons expressing the T767I mutation. In addition to
spontaneous ﬁring, the evoked ﬁring of transfected pyramidal neurons
was examined. The threshold for the ﬁrst action potential for cells
expressing T767I mutant channels was 25 ± 6 pA (n = 13) which is
less than half of the threshold in cells expressing WT channels (64 ±
13 pA; n = 8) (p b 0.05) (Figs. 4A, B). Basic properties of the action
potentials elicited at threshold were not different for cells expressing
either Nav1.6-WT or T767I (Table 1). The average number of spikes elic-
ited in response to graded 1 second step current injections was signiﬁ-
cantly increased (ANOVA, p b 0.05) in hippocampal neurons expressing
the T767I compared toWT channels (Fig. 4C). All of the observed chang-
es are predicted to increase the activity of neurons expressing the
mutant channel.
Discussion
The severity of epileptic encephalopathy in the patient and the
absence of a family history of neurological disorders suggested that
the underlying cause might involve a dominant de novo mutation.
Whole exome sequencing of the proband identiﬁed the de novo variant
p.Thr767Ile in Nav1.6. Functional testing demonstrated that this is a
gain-of-function mutation, with a signiﬁcant shift in the voltage depen-
dence of channel activation in a hyperpolarizing direction. In addition,
the ramp current is increased three-fold compared to that of the WT
channels. These properties are predicted to increase excitability ofTable 1
Properties of action potentials recorded from pyramidal neurons expressing either WT
Nav1.6 or T767I mutant channels.
Action potential Threshold Amplitude Slope Half-width
WT 64 ± 13 pA 82 ± 5 mV 18 ± 4 mV/ms 4.8 ± 0.7 ms
T767I 25 ± 6 pA⁎ 86 ± 5 mV 33 ± 12 mV/ms 5.0 ± 0.5 ms
⁎ p b 0.05 (ANOVA).neurons expressing the mutant channel, and this was conﬁrmed using
current-clamp recordings in pyramidal hippocampal neurons. Our
data provide compelling evidence that p.Thr767Ile causes hyperexcit-
ability of excitatory neurons resulting in the severe epileptic encepha-
lopathy in this patient.
The evolutionary conservation of the threonine 767 residue in DII/S1
and the invariance of this residue in the nine human paralogs of the
voltage-gated sodium channel gene suggest an important contribution
to channel function. The replacement of the polar threonine residue
by the branched hydrophobic isoleucine residue in a transmembrane
domain also predicts a functional effect on channel properties. Indeed,
voltage-clamp recording demonstrates that the half-activation voltage
of the mutant channel is shifted by 10.8 mV in a hyperpolarizing direc-
tion, indicating that the channel will activate in response to weaker
stimuli compared to WT channels. Additionally, the 3-fold increase
and hyperpolarizing shift of the voltage of the peak ramp current of
themutant channel indicates that it can boost depolarization byweaker
stimuli compared to WT channels, thus increasing the probability that
neurons reach the threshold for the all-or-none action potential. These
proexcitatory changes in the gating properties of the p.Thr767Ile
mutant channel may be somewhat attenuated by the reduction in the
current density ofmutant channels. The dominance of the proexcitatory
changes, however, is manifested at the neuronal level by the signiﬁcant
increase in the fraction of hippocampal neurons expressing p.Thr767Ile
channels that display spontaneous ﬁring (40%), compared to those
expressing WT channels (6%), and by the lower threshold for evoked
single action potential and increased number of spikes in response to
a graded stimulus in neurons expressing the mutant channel. Thus
neurons that express the mutant p.Thr767Ile channels in addition to
their endogenous channels are more excitable than those expressing
wildtype channels, consistent with an epileptic phenotype. Regardless
of the precise ratio of mutant to wildtype channels in a heterozygous
neuron, the premature opening of mutant channels at hyperpolarized
potential is predicted to result in neuronal hyperexcitability.
Fig. 4. Neurons expressing Nav1.6-T767I are hyperexcitable compared to those expressing
theWT channel. Selected traces illustrating action potentials elicited near threshold stimulus
current injections for Nav1.6-T767I expressing (A) and Nav1.6-WT expressing (B) pyramidal
hippocampal neurons. (C) The average number of spikes elicited to one second long current
injections of 0 pA to 40 pA in 5 pA increments from hippocampal pyramidal neurons
expressing WT (black symbols, N = 8) or T767I (red symbols, N = 13) channels. The in-
crease of the response for T767I expressing neurons was signiﬁcant by ANOVA (p b 0.05).
Data presented as mean ± SEM.
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Nav1.6 that increase excitatory pyramidal neuron excitability. A role
for Nav1.6 in excitatory neurons and susceptibility to epileptic seizures
is consistent with recent studies of the RNA binding protein CELF4,
that is expressed primarily in excitatory neurons of the cerebral cortex
and hippocampus of the mouse. The knockout of Celf4 is proepileptic,
and the complex seizure disorder in the Celf mutant mice has been
linked to increased sodium currents and increased concentration of
Nav1.6 at the axon initial segment of excitatory neurons (Sun et al.,
2012). Similarly, in the period following electrical induction of status
epilepticus in the mouse, there is an increase in the abundance of
Nav1.6 at the axon initial segment (Hargus et al., 2013). Heterozygous
Scn8a null mice exhibit spike-wave discharges and absence seizures
(Papale et al., 2009), suggesting that loss-of-function mutations may
also cause some forms of epilepsy, possibly due to a differential impact
on inhibitory neurons where Nav1.6 is also expressed (Lorincz and
Nusser, 2008). However, reduced abundance of Nav1.6 in heterozygous
null mice is also protective against kainate-induced epilepsy and re-
duces seizures in compound heterozygotes carrying an SCNA1 Dravetmutation (Blumenfeld et al., 2009; Martin et al., 2007; Papale et al.,
2009). The pro-seizure effects of increased Nav1.6 activity and the
protective effect of haploinsufﬁciency both support the pathogenicity
of gain-of-function mutations of human Nav1.6 that increase channel
activity in excitatory pyramidal neurons.
The clinical phenotype of the patient described here is more severe
than in the previous case of de novo SCN8Amutation (Veeramah et al.,
2012), with seizure onset at 2 weeks compared with six months, im-
paired development rather than developmental delay and regression,
and a different seizure proﬁle. Both of the Nav1.6 mutations result in
gain-of-function attributes whichmake them pathogenic in the hetero-
zygous state. Pyramidal hippocampal neurons expressing either of
these mutant channels are hyperexcitable compared to neurons ex-
pressing wildtype channels. Nonetheless the changes in channel prop-
erties are distinct at the biophysical level, with impaired channel
inactivation and increased persistent current in the previous case and
enhanced activation in the present case. Both of the SCN8A mutations
also result in increased ramp current, which has also been reported for
epileptogenic mutations of SCN3A (Vanoye et al., 2013). The data indi-
cate that alterations in multiple parameters can lead to neuronal hy-
perexcitability in epileptic encephalopathy, and demonstrate the
importance of functional evaluation of multiple mutations for under-
standing genotype/phenotype relationships. Comparison of neuronal
ﬁring patterns in mouse models of the two gain-of-function mutations
could provide insight into the cellular origin of seizures and the more
severe phenotypic effect of the p.Thr767Ile mutation.
Although candidate gene sequencing has become a clinical diag-
nostic tool for patients with epilepsy, the majority of sporadic cases
remain of unknown etiology. The advent of next generation sequenc-
ing methods has accelerated the unbiased approach to discovery of
new targets in epilepsy research. Since our report of the ﬁrst de
novo gain-of-function mutation in SCN8A (Veeramah et al., 2012),
an additional eleven de novo variants have been observed in patients
with epileptic encephalopathy or intellectual disability; these in-
clude R1617Q in domain III/S4 (Rauch et al., 2012), R662C in L1,
L1331V in DIII/S5 and R1872Q in the C-terminus (Carvill et al.,
2013). In silico analysis predicts that several of these new mutations
may be pathogenic (Carvill et al., 2013; Rauch et al., 2012). The com-
bination of genetic and functional data provided here for the T767I
mutation provides compelling evidence that it is a second pathogen-
ic mutation in Nav1.6 in a patient with epileptic encephalopathy.
Functional analysis of additional mutations will provide a broader
understanding of the relationship between molecular lesions and
clinical course. The rapid increase in identiﬁcation of SCN8A muta-
tions suggests that it will prove to be an important causative gene
in infantile epilepsy.
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